The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Cliffs Natural Resources Inc. (NYSE: CLF) shares have fallen sharply this past week after reporting third quarter profit declined 86 percent to $85.1 million. For 2012, the company has reduced its U.S. iron ore sales volume expectation to 22 million tons from its previous expectation of 23 million tons.

Find out more about Cliffs Natural Resources including full access to the free equity report at: www.BedfordReport.com/CLF

ImmunoGen, Inc. (NASDAQ: IMGN) shares declined 16 percent after reporting losses widened to $25.2 million in the fiscal first quarter, from to a net loss of $19.5 million in the year-ago quarter. The company expects to file for marketing approval of its cancer drug T-DM1 in 2015.

Find out more about ImmunoGen including full access to the free equity report at: www.BedfordReport.com/IMGN

Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) earlier this month received positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use recommending approval of a marketing authorization in the European Union for KRYSTEXXA. The company will release third quarter results on November 8, 2012.

Find out more about Savient Pharmaceuticals including full access to the free equity report at: www.BedfordReport.com/SVNT

TeleCommunication Systems, Inc. (NASDAQ: TSYS) shares of the wireless communications company soared 17 percent Friday after reporting third quarter revenue increased 24 percent to a record of $140.1 million.

Find out more about TeleCommunication Systems including full access to the free equity report at: www.BedfordReport.com/TSYS

Disclaimer: Equity News Circuit is not a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security. A third party, bedfordreport.com, has paid Equity News Circuit four hundred and fifty dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, have a financial relationship with any company whose stock is mentioned in this release.

Contact Information: Equity News Circuit Email Contact

ImmunoGen (NASDAQ:IMGN)
Historical Stock Chart
From Jul 2024 to Aug 2024 Click Here for more ImmunoGen Charts.
ImmunoGen (NASDAQ:IMGN)
Historical Stock Chart
From Aug 2023 to Aug 2024 Click Here for more ImmunoGen Charts.